Although the current studies suggest that CD36 contributes to the development of T2DM on two levels, insulin resistance and pancreatic β-cell dysfunction and damage [116,117], the role of CD36 in the pathogenesis of DM is unclear. Here, CD36 is linked to Insulin resistance.